LUNSEKIMIG
UNII VYR5R5XN5A

Substance Identification & Data

This profile provides standardized clinical and technical data for Lunsekimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VYR5R5XN5A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2770858-49-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VYR5R5XN5A

CAS Registry Number

2770858-49-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUNSEKIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203158

National Cancer Institute reference terminology for clinical and research data.

INN ID

12833

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-280

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lunsekimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LUNSEKIMIG

Common Names & Synonyms

IMMUNOGLOBULIN SINGLE CHAIN OF 5 VH (SC-5-VH), ANTI-(HOMO SAPIENS IL13 (INTERLEUKIN 13, IL-13)), ANTI-(HOMO SAPIENS TSLP (THYMIC STROMAL LYMPHOPOIETIN)) AND ANTI-(HOMO SAPIENS ALB (ALBUMIN, HUMAN SERUM ALBUMIN, HAS)), MONOCLONAL ANTIBODY SC-5-VH, HUMANIZED AND CHIMERIC, TRISPECIFIC, PENTAVALENT

LUNSEKIMIG [INN]

LUNSEKIMIG [USAN]

LUNSEKIMIG [WHO-DD]

External Clinical & Regulatory Resources

Previous UNIIVYR55UWU8M

Next UNIIVYS174Q62V